Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open Label Adaptive Design Study To Evaluate D1 Receptor Occupancy (ro) Following Single Dose Of Pf-06412562, Using Positron Emission Tomography (Pet) With Ligand [11c]sch23390 In Healthy Male Subjects

Next Previous
Trial Profile

Open Label Adaptive Design Study To Evaluate D1 Receptor Occupancy (ro) Following Single Dose Of Pf-06412562, Using Positron Emission Tomography (Pet) With Ligand [11c]sch23390 In Healthy Male Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 31 Dec 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PF 6412562 (Primary)
  • Indications Cognition disorders; Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors Pfizer

Most Recent Events

  • 23 Nov 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
  • 28 Oct 2014 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.
  • 05 Oct 2014 Planned End Date changed from 1 Oct 2014 to 1 Feb 2015, as per ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top